The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.

This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...

OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a ...

Complete the form below to download the infographic. Cell-line development (CLD) is crucial for generating therapeutic ...

Complete the form below to view the video. Generating monoclonal cell lines is fundamental to developing biomolecules like ...

Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or hybridoma ...

DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...

At Hayward Field, the roar of the crowd is familiar, not just from collegiate competition, but from years of growing up in the stands, watching,... Think about your favorite medicine. Maybe it is a ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

If you’ve ever had to pause a promising experiment while waiting on titer results, you’re not alone. In many labs, samples come off the bioreactor only to sit in line for ELISA or HPLC - and decisions ...

Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility. Integrated automation ...